High 8.3HealthcarePublished Apr 25, 2022

CVE-2022-1459Non-Privilege User Can View Patient’s Disclosures in openemr/openemr

Updated under an hour ago (Oct 26, 2026, 6:20 PM ET)

Does this affect you?

It affects openemr/openemr and 1 other product. Add what you run to find out whether that includes you.

EPSS puts the chance of exploitation in the next 30 days at 1.06%, higher than 64% of scored CVEs.

Do this next

Start free and add your stack

Free account, 1 product

Every CVE for openemr/openemr

Exploited in the last 30 days

Non-Privilege User Can View Patient’s Disclosures in GitHub repository openemr/openemr prior to 6.1.0.1.

CVSS: 8.3 HIGH (v3.0, CNA)CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L
Weakness (CWE): CWE-1118
Known exploited: Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days): 1.06% (percentile 64)
Assigned by: @huntrdev
NVD analysis: Modified
Record last updated: Aug 2, 2024
First seen by InfoSec Signals: Oct 12, 2026

Affected products

Affected products

openemr openemr/openemr openemr:openemr (from the name)	from unspecified before 6.1.0.1	CNA record
open-emr openemr open-emr:openemr	before 6.1.0.1	NVD

References

References

https://huntr.dev/bounties/9023ca9b-a601-4e5d-8952-640c60d029f1	x-refsource-confirm, exploit, patch, third-party-advisory
https://github.com/openemr/openemr/commit/8f8a97724c0e8fcc4096b4b30af9aaf064ada45a	x-refsource-misc, patch, third-party-advisory

The CVE record on cve.org NVD's entry

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.